These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3522450

  • 1. Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects.
    Golay A, Schutz Y, Felber JP, de Fronzo RA, Jéquier E.
    Int J Obes; 1986; 10(2):107-16. PubMed ID: 3522450
    [Abstract] [Full Text] [Related]

  • 2. Evolution of glucose induced thermogenesis in obese subjects with and without diabetes: a six-year follow-up study.
    Golay A, Jallut D, Schutz Y, Felber JP, Jéquier E.
    Int J Obes; 1991 Sep; 15(9):601-7. PubMed ID: 1960011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Ravussin E, Bogardus C, Schwartz RS, Robbins DC, Wolfe RR, Horton ES, Danforth E, Sims EA.
    J Clin Invest; 1983 Sep; 72(3):893-902. PubMed ID: 6350368
    [Abstract] [Full Text] [Related]

  • 5. Relationship between autonomic neuropathy and thermogenesis in non diabetic and diabetic obese patients.
    Golay A, Schutz Y, Dusmet M, Felber JP, Jequier E.
    Diabete Metab; 1987 Feb; 13(1):52-7. PubMed ID: 3569633
    [Abstract] [Full Text] [Related]

  • 6. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R, Deibert D, Hendler R, Felig P, Soman V.
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [Abstract] [Full Text] [Related]

  • 7. Blunted glucose-induced thermogenesis: a factor contributing to relapse of obesity.
    Golay A.
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S23-7. PubMed ID: 8384175
    [Abstract] [Full Text] [Related]

  • 8. [The effect of body weight on insulin activity].
    Sindelka G, Skrha J, Prázný M, Hilgertová J.
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
    Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G.
    Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glucose-induced thermogenesis in obese subjects with or without familial history of obesity.
    Verga S, Buscemi S, Bompiani G.
    Eur J Clin Nutr; 1990 May; 44(5):397-404. PubMed ID: 2387274
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.
    Potter van Loon BJ, Radder JK, Frölich M, Krans HM, Zwinderman AH, Meinders AE.
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S55-61. PubMed ID: 1338387
    [Abstract] [Full Text] [Related]

  • 17. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ, Jia WP, Zhu M, Lu JX, Chen L, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1781-4. PubMed ID: 15631773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Postprandial thermogenesis and obesity: effects of glucose and fructose].
    Macor C, De Palo C, Vettor R, Sicolo N, De Palo E, Federspil G.
    Minerva Endocrinol; 1990 Nov 02; 15(4):273-7. PubMed ID: 2099997
    [Abstract] [Full Text] [Related]

  • 20. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M, Khalfallah Y, Laville M, Sautot G, Dechaud H, Serusclat P, Berthezene F, Riou JP, Mornex R.
    Diabete Metab; 1987 Nov 02; 13(4):450-6. PubMed ID: 3315766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.